1. Home
  2. LGL vs PMN Comparison

LGL vs PMN Comparison

Compare LGL & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGL
  • PMN
  • Stock Information
  • Founded
  • LGL 1917
  • PMN 2004
  • Country
  • LGL United States
  • PMN Canada
  • Employees
  • LGL N/A
  • PMN N/A
  • Industry
  • LGL Industrial Machinery/Components
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • LGL Technology
  • PMN Health Care
  • Exchange
  • LGL Nasdaq
  • PMN Nasdaq
  • Market Cap
  • LGL 35.6M
  • PMN 17.0M
  • IPO Year
  • LGL N/A
  • PMN N/A
  • Fundamental
  • Price
  • LGL $6.96
  • PMN $0.45
  • Analyst Decision
  • LGL
  • PMN Strong Buy
  • Analyst Count
  • LGL 0
  • PMN 2
  • Target Price
  • LGL N/A
  • PMN $4.50
  • AVG Volume (30 Days)
  • LGL 41.7K
  • PMN 49.4K
  • Earning Date
  • LGL 08-12-2025
  • PMN 08-07-2025
  • Dividend Yield
  • LGL N/A
  • PMN N/A
  • EPS Growth
  • LGL 204.51
  • PMN N/A
  • EPS
  • LGL 0.08
  • PMN N/A
  • Revenue
  • LGL $4,322,000.00
  • PMN N/A
  • Revenue This Year
  • LGL N/A
  • PMN N/A
  • Revenue Next Year
  • LGL N/A
  • PMN N/A
  • P/E Ratio
  • LGL $94.50
  • PMN N/A
  • Revenue Growth
  • LGL 20.66
  • PMN N/A
  • 52 Week Low
  • LGL $5.03
  • PMN $0.43
  • 52 Week High
  • LGL $9.74
  • PMN $2.37
  • Technical
  • Relative Strength Index (RSI)
  • LGL 50.69
  • PMN 38.45
  • Support Level
  • LGL $6.90
  • PMN $0.48
  • Resistance Level
  • LGL $9.74
  • PMN $0.50
  • Average True Range (ATR)
  • LGL 1.01
  • PMN 0.03
  • MACD
  • LGL 0.02
  • PMN -0.00
  • Stochastic Oscillator
  • LGL 27.98
  • PMN 15.44

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: